Location: Home
  • search
  • go
  • Relate News
  • 1/29/2019Boehringer Ingelheim Launches First Swine Vaccines Produced in China
  • 1/28/2019Advent International Makes Majority Investment in CRO Bioduro
  • 1/18/2019MabPlex's Manufactured mAb Receives IND Approval from the U.S. FDA
  • 1/17/2019Boehringer Ingelheim Expands Biopharma Commercial Manufacturing in Chi...
  • 1/8/2019CANbridge Pharma and WuXi Biologics Expand Rare Disease Therapeutics P...
  • 12/10/2018WuXi AppTec Expands Site in California for Pharmaceutical R&D ...
  • 12/5/2018Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...
  • 12/5/2018Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite
  • 11/29/2018WuXi Biologics and ABL Enter Development and Clinical Manufacturing Pa...
  • 11/29/2018Datwyler to Enter China to Meet Needs for Injectable Drug Components
  • 11/27/2018WuXi Biologics Begins Construction of A Major Biologics Center in Shan...
  • 11/7/2018GE to Produce Single-Use Consumables in China thru Collaboration with ...
  • 10/25/2018WuXi AppTec Launches Drug Screening Library
  • 9/27/2018PharmaBlock Acquires Manufacturing Facility in China
  • 9/20/2018Wuxi AppTech Submitted $1B+ IPO Application in Hong Kong
  • 9/11/2018WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manu...
  • 9/11/2018China CDMO Market 2018-2021: The R&D Cost of New Drugs Continues t...
  • 9/3/2018Boehringer Teams Up with Tsinghua University for Joint R&D in Immu...
  • 9/3/2018Boehringer Supports BeiGene in Its China NDA Submission for Tislelizum...
  • 7/25/2018WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspection
  • 7/20/2018WuXi STA and Antengene Sign Development and Manufacturing Agreement
  • 7/18/2018New Report: China's CDMO Market to Boom by 2021
  • 7/4/2018Boehringer Ingelheim Extends "One-Stop-Shop" Service with Ne...
  • 6/25/2018WuXi Biologics and Harbour BioMed Announce Strategic Partnership
  • 6/20/2018Wuxi Biologics Initiated Construction of Integrated ADC Solution Cente...
  • 6/12/2018Chinese Government Launch Support Program for Biopharma CRO and CMO Se...
  • 6/11/2018WuXi Biologics to Build a $60M Biologics Facility in the U.S.
  • 6/5/2018Sinobioway Biomedicine to Invest Nearly $500M in Massive Biologics Sit...
  • 5/31/2018FORMA Therapeutics and HitGen Initiate Multiyear Research Collaboratio...
  • 5/29/2018WuXi To Build Biologics Center In Northern China
  • Page:9/19 Total number of articles:545: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group